RESPIR-HVS: Impact of Respiratory Rehabilitation on Quality of Life in Patients With Hyperventilation Syndrome
Study Details
Study Description
Brief Summary
The hyperventilation syndrome is a quite frequent pathology, affecting up to 10% of the general population and 40% of the asthmatic population. Its physiopathology is still badly known and even if it is a benign affection, its associated comorbidities and symptomatology greatly decrease the patients' quality of life. Yet, no medicinal treatments have been proved useful, but prescribers noticed improvements after physiotherapy. Given that the physiotherapy impact on hyperventilation syndrome is not well described in the literature, this study aims to scientifically ascertain physiotherapy benefits on quality of life and symptomatology in hyperventilation syndrome-suffering patients.
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
N/A |
Study Design
Arms and Interventions
| Arm | Intervention/Treatment |
|---|---|
| Other: Control group Group 1 (Control Group) will not immediately receive respiratory rehabilitation but between the 2nd and 4th months postdiagnosis. |
Other: Respiratory rehabilitation
Respiratory rehabilitation includes education, hypoventilation exercises, diaphragmatic breathing exercises, relaxation, retraining, others.
|
| Other: Intervention group Group 2 (Intervention Group) will immediately receive rehabilitation between the diagnosis and the 2nd month postdiagnosis. |
Other: Respiratory rehabilitation
Respiratory rehabilitation includes education, hypoventilation exercises, diaphragmatic breathing exercises, relaxation, retraining, others.
|
Outcome Measures
Primary Outcome Measures
- Incidence of respiratory rehabilitation on Quality of life [Day 0]
Quality of life will be evaluated with the SF-36 score
- Incidence of respiratory rehabilitation on Quality of life [Month 2]
Quality of life will be evaluated with the SF-36 score
- Incidence of respiratory rehabilitation on Quality of life [Month 4]
Quality of life will be evaluated with the SF-36 score
Secondary Outcome Measures
- Change in symptomatology [Day 0]
Change in symptomatology will be evaluated on the Nijmegen questionnaire
- Change in symptomatology [Month 2]
Change in symptomatology will be evaluated on the Nijmegen questionnaire
- Change in symptomatology [Month 4]
Change in symptomatology will be evaluated on the Nijmegen questionnaire
Eligibility Criteria
Criteria
Inclusion Criteria:
-
Positive hyperventilation syndrome diagnosis
-
Having a social security insurance
-
Being at least 18 years old
-
Having given their written consent
Exclusion Criteria:
-
Being put under guardianship or curatorship
-
Having seen a physiotherapist for a respiratory rehabilitation in the last three months
-
Suffering from a chronic and degenerative pathology (chronic obstructive pulmonary disease, Parkinson's disease, idiopathic fibrosis, …)
-
Not being able to receive the respiratory rehabilitation from our care providers
-
Already having received a rehabilitation for hyperventilation syndrome
-
Not speaking French or not being unable to complete the questionnaires
Contacts and Locations
Locations
| Site | City | State | Country | Postal Code | |
|---|---|---|---|---|---|
| 1 | CHR d'Orléans | Orléans | France |
Sponsors and Collaborators
- Centre Hospitalier Régional d'Orléans
Investigators
- Principal Investigator: Louis-François BIRNESSER, CHR Orléans
Study Documents (Full-Text)
None provided.More Information
Publications
- Chenivesse C, Similowski T, Bautin N, Fournier C, Robin S, Wallaert B, Perez T. Severely impaired health-related quality of life in chronic hyperventilation patients: exploratory data. Respir Med. 2014 Mar;108(3):517-23. doi: 10.1016/j.rmed.2013.10.024. Epub 2013 Nov 7.
- Gardner WN. The pathophysiology of hyperventilation disorders. Chest. 1996 Feb;109(2):516-34. Review.
- Hoes MJ, Colla P, Folgering H. Clomipramine treatment of hyperventilation syndrome. Pharmakopsychiatr Neuropsychopharmakol. 1980 Jan;13(1):25-8.
- Jones M, Harvey A, Marston L, O'Connell NE. Breathing exercises for dysfunctional breathing/hyperventilation syndrome in adults. Cochrane Database Syst Rev. 2013 May 31;(5):CD009041. doi: 10.1002/14651858.CD009041.pub2. Review.
- Kraft AR, Hoogduin CA. The hyperventilation syndrome. A pilot study on the effectiveness of treatment. Br J Psychiatry. 1984 Nov;145:538-42.
- Lewis RA, Howell JB. Definition of the hyperventilation syndrome. Bull Eur Physiopathol Respir. 1986 Mar-Apr;22(2):201-5.
- Lewis T, Cotton, Barcroft J, Dufton D, Milroy TR, Parsons TR. BREATHLESSNESS IN SOLDIERS SUFFERING FROM IRRITABLE HEART. Br Med J. 1916 Oct 14;2(2911):517-9.
- Nixon PG. Effort syndrome: hyperventilation and reduction of anaerobic threshold. Biofeedback Self Regul. 1994 Jun;19(2):155-69.
- Thomas M, McKinley RK, Freeman E, Foy C. Prevalence of dysfunctional breathing in patients treated for asthma in primary care: cross sectional survey. BMJ. 2001 May 5;322(7294):1098-100.
- Van De Ven LL, Mouthaan BJ, Hoes MJ. Treatment of the hyperventilation syndrome with bisoprolol: a placebo-controlled clinical trial. J Psychosom Res. 1995 Nov;39(8):1007-13.
- van Dixhoorn J, Duivenvoorden HJ. Efficacy of Nijmegen Questionnaire in recognition of the hyperventilation syndrome. J Psychosom Res. 1985;29(2):199-206.
- Vansteenkiste J, Rochette F, Demedts M. Diagnostic tests of hyperventilation syndrome. Eur Respir J. 1991 Apr;4(4):393-9.
- CHRO-2020-19